Prostate cancer (PCa) affects 1 in 8 men in the United Kingdom annually 1, with a mortality rate second only to lung cancer (in men) 2. The 5-year survivability rate drop between those diagnosed with ...

This large-scale, high-quality trial compares a promising alternative screening test to PSA. This may be the breakthrough for prostate cancer screening that we have all been waiting for,” said Kevin C ...

Prostate-specific membrane antigen, or PSMA, -targeted PET imaging for prostate cancer has been a breakthrough diagnosis tool in locating prostate cancer tumors for more precise treatment. The new ...

This is read by an automated voice. Please report any issues or inconsistencies here. Current prostate cancer screening methods often yield false positives. This results in unnecessary biopsies and ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...